glp-1 receptor agonist pancreatitis risk meta-analysis Evaluating the Rates of and Pancreatic Cancer Among GLP‐1 Agonists: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials - Wen - 2025 - Endocrinology, Diabetes & Metabolism GLP-1 RAs and Pancreatitis: No

Given the heterogeneity in study design, populations, intervention duration, and clinical endpoints, findings were interpreted with careful consideration of variability across the evidence base

India Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry

Saxenda may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, increased heart rate, abdominal pain, reflux, gas and dizziness

GLP-1 may act on bone by promoting bone formation, inhibiting bone resorption, and affecting the coordination of the two processes

Discussion The current review explores the evolving role of GLP-1RAs in the management of various pain conditions, beyond their traditional application in metabolic diseases